HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hitoshi Hirakawa Selected Research
Hitoshi Hirakawa Research Topics
Disease
15
Neoplasms (Cancer)
08/2022 - 12/2005
13
Head and Neck Neoplasms (Head and Neck Cancer)
06/2022 - 03/2013
12
Squamous Cell Carcinoma of Head and Neck
12/2021 - 08/2009
5
Neoplasm Metastasis (Metastasis)
06/2021 - 12/2013
5
Hypopharyngeal Neoplasms
06/2020 - 02/2014
5
Carcinoma (Carcinomatosis)
04/2018 - 01/2013
3
Infections
10/2021 - 08/2018
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2021 - 01/2016
3
Papillomavirus Infections
03/2019 - 08/2018
3
Cysts
08/2018 - 04/2005
2
Oropharyngeal Neoplasms
06/2022 - 01/2016
2
Extranodal Extension
12/2021 - 07/2013
2
Papilloma (Papillomatosis)
10/2021 - 03/2021
2
Laryngeal Neoplasms (Laryngeal Cancer)
02/2017 - 11/2014
1
Goiter
09/2020
1
Squamous Cell Neoplasms (Squamous Cell Cancer)
03/2019
1
Branchioma (Branchial Cleft Cysts)
08/2018
1
Weight Loss (Weight Reduction)
04/2018
1
B-Cell Lymphoma (Lymphoma, B Cell)
02/2018
1
Stomatitis
02/2017
1
Nausea
02/2017
1
Dermatitis
02/2017
1
Deglutition Disorders (Dysphagia)
02/2017
1
Xerostomia
04/2016
1
Pharyngeal Neoplasms
08/2014
1
Lymphatic Metastasis
02/2014
1
Surgical Wound Infection
03/2013
1
Ductal Carcinoma
01/2013
1
Pleomorphic Adenoma
01/2013
1
Disease Progression
01/2013
1
Teratoma (Teratoid Tumor)
12/2009
1
Ulcerative Colitis
10/2009
1
Diarrhea
10/2009
Drug/Important Bio-Agent (IBA)
7
Cisplatin (Platino)
FDA Link
Generic
06/2020 - 12/2005
4
Docetaxel (Taxotere)
FDA Link
06/2022 - 08/2009
4
Nivolumab
IBA
01/2022 - 03/2021
4
DNA (Deoxyribonucleic Acid)
IBA
02/2020 - 08/2018
3
Proteins (Proteins, Gene)
FDA Link
10/2021 - 04/2005
3
Fluorouracil (Carac)
FDA Link
Generic
06/2020 - 02/2018
3
Biomarkers (Surrogate Marker)
IBA
03/2019 - 02/2018
2
nedaplatin
IBA
06/2022 - 06/2022
2
Viral DNA
IBA
10/2021 - 03/2021
2
Messenger RNA (mRNA)
IBA
10/2021 - 02/2018
1
Antineoplastic Agents (Antineoplastics)
IBA
06/2022
1
Antibodies
IBA
10/2021
1
Cetuximab (Erbitux)
FDA Link
06/2021
1
Indocyanine Green (Cardio-Green)
FDA Link
Generic
06/2021
1
RNA (Ribonucleic Acid)
IBA
03/2021
1
Sirolimus (Rapamycin)
FDA Link
01/2021
1
Eosine Yellowish-(YS) (Eosin)
IBA
09/2020
1
Capsules (Microcapsules)
IBA
09/2020
1
Hematoxylin (Haematoxylon)
IBA
09/2020
1
O-(glucuronic acid 2-sulfate)-(1--3)-O-(2,5)-andydrotalitol 6-sulfate
IBA
07/2019
1
Xenobiotics
IBA
07/2019
1
Cytochrome P-450 CYP1A1 (CYP1A1)
IBA
07/2019
1
Carcinogens
IBA
07/2019
1
HPV DNA Probes
IBA
08/2018
1
Fatty Acids (Saturated Fatty Acids)
IBA
04/2018
1
Magnesium
IBA
02/2018
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
02/2018
1
multidrug resistance-associated protein 1
IBA
02/2018
1
Equilibrative Nucleoside Transporter 1
IBA
02/2018
1
ErbB Receptors (EGF Receptor)
IBA
02/2018
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
02/2018
1
Tensins
IBA
02/2018
1
E2F Transcription Factors
IBA
02/2018
1
human ERBB2 protein
IBA
02/2018
1
Tubulin
IBA
02/2018
1
Thymidylate Synthase
IBA
02/2018
1
Phosphorylases (Glucan Phosphorylase)
IBA
02/2018
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2018
1
Co-Repressor Proteins
IBA
02/2018
1
Glutathione S-Transferase pi
IBA
02/2018
1
Orotate Phosphoribosyltransferase
IBA
02/2018
1
Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)
IBA
02/2018
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
02/2018
1
Hemoglobins (Hemoglobin)
IBA
02/2017
1
Biological Products
IBA
03/2016
1
Pharmaceutical Preparations
IBA
02/2015
1
Indicators and Reagents (Reagents)
IBA
02/2014
1
Epidermal Growth Factor (EGF)
IBA
01/2013
1
Trastuzumab (Herceptin)
FDA Link
01/2013
1
Growth Hormone (Somatotropin)
IBA
10/2009
1
Prednisolone (Predate)
FDA Link
Generic
10/2009
1
Mesalamine (Mesalazine)
FDA Link
Generic
10/2009
1
Irinotecan (Camptosar)
FDA Link
Generic
09/2009
Therapy/Procedure
12
Chemoradiotherapy
06/2022 - 10/2012
8
Neck Dissection (Radical Neck Dissection)
08/2022 - 03/2013
6
Drug Therapy (Chemotherapy)
01/2022 - 01/2002
5
Radiotherapy
12/2021 - 07/2013
5
Induction Chemotherapy
06/2020 - 05/2013
4
Therapeutics
04/2018 - 10/2009
2
Neoadjuvant Therapy
11/2017 - 01/2016
2
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
04/2016 - 01/2016
1
Molecular Targeted Therapy
10/2021
1
Perioperative Period
04/2018
1
Free Tissue Flaps
04/2018
1
Metastasectomy
12/2013
1
Operative Surgical Procedures
03/2013
1
Punctures
12/2009